ViroGates A/S

ViroGates A/S EBITDA per Share

The EBITDA per Share of ViroGates A/S (VIRO.CO) as of Oct 16, 2026 is -1.66 DKK. In the previous year, EBITDA per Share was -2.17 DKK — a change of -23.68% (higher).

EBITDA per Share

-1.66DKK

YoY

-23.68%

Last updated:

EBITDA per Share of ViroGates A/S is 2025 -1.66 DKK. EBITDA per Share of ViroGates A/S was 2024 -2.17 DKK. It decreases by -23.68% higher compared to the previous year.

The ViroGates A/S EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-5.19 DKK
Jan 1, 2019
-6.50 DKK
Jan 1, 2020
-6.32 DKK
Jan 1, 2021
-5.93 DKK
Jan 1, 2022
-2.50 DKK
Jan 1, 2023
-1.95 DKK
Jan 1, 2024
-2.17 DKK
Jan 1, 2025
-1.66 DKK
The ViroGates A/S EBITDA per Share history
YEAREBITDA per ShareYoY
-1.66DKK-23.68%
-2.17DKK+11.45%
-1.95DKK-21.96%
-2.50DKK-57.89%
-5.93DKK-6.20%
-6.32DKK-2.76%
-6.50DKK+25.33%
-5.19DKK+96.63%
-2.64DKK+258.21%
-0.74DKK+30.09%
-0.57DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

ViroGates A/S Stock analysis

What does ViroGates A/S do? ViroGates A/S, listed on the Copenhagen Stock Exchange with ticker VIRO.CO, operates in the Health Care sector. The company develops and markets diagnostic products, including the suPARnostic line, which measures soluble urokinase Plasminogen Activator Receptor (suPAR) in blood. suPAR levels indicate immune activation and are linked to infectious diseases such as HIV-1, malaria, tuberculosis, and sepsis. suPARnostic offers a Quantitative Point of Care Quick Triage test for acute care triage and a Quantitative ELISA Assay for clinical use. The company has 28 employees and was listed in 2018. ViroGates A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ViroGates A/S stock

EBITDA per Share of ViroGates A/S is -1.66 DKK in 2025.

EBITDA per Share of ViroGates A/S changed from -2.17 DKK to -1.66 DKK, representing a -23.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share ViroGates A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — ViroGates A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — ViroGates A/S